Continued Financial Strength and Excellence in Programming Technologies; Announces $2 Million Share Repurchase Program REDMOND, Wash., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Data I/O Corporation (NASDAQ: DAIO), a leading global provider of advanced data …
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), a pioneer in data security and analytics, today announced its participation at the following upcoming conferences: The Needham Security and Networking Conference in New York …
MCLEAN, Va., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Gladstone Investment Corporation (NASDAQ: GAIN) announces the following event: What: Gladstone Investment Corporation’s Second Quarter Ended September 30, 2018 Earnings Call & Webcast When: Tuesday, …
-Company continues enrollment in Phase 1b navicixizumab trial following encouraging single agent and interim combination results in ovarian cancer; -Prepares for presentation of etigilimab data at Society for Immunotherapy of Cancer (SITC) Annual Meeting …
SHERMAN OAKS, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Cherokee Global Brands (NASDAQ: CHKE), a global brand marketing platform that manages a growing portfolio of fashion and lifestyle brands, today announced that it has appointed Evan Hengel to the …
Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced …
DURHAM, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Thursday, November 8, 2018 at 4:30 p.m. ET to discuss third quarter 2018 financial results and recent operational highlights. A …
BOSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced today that on October …
Q1 2019 Total Revenue of $100.5 million, up 26% year-over-year Q1 2019 Recurring Revenue of $99.3 million, up 26% year-over-year SCHAUMBURG, Ill., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (NASDAQ: PCTY), a leading provider of cloud- …
WEST CHESTER, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin …
Net Sales Growth of 11.2% RIDGEFIELD, Conn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (NASDAQ: CHEF), a premier distributor of specialty food products in the United States and Canada, today reported financial results for its third …
WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, today provided an update on the …
Regular Quarterly Dividend of $0.39 Per Share Declared for Fourth Quarter 2018 Board of Directors Declared Special Cash Dividend of $0.04 Per Share EVANSTON, Ill., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the …
Third quarter revenue grows 62 percent year over year to $111.0 million Total paid membership grows 18 percent year over year to 22.6 million Third quarter total visits grow 110 percent year over year to 641,000 PURCHASE, NY, Nov. 01, 2018 (GLOBE NEWSWIRE) …
NESS ZIONA, Israel, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug …
ANN ARBOR, Mich., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with …
Bookings of $1.1 billion, resulting in a book-to-bill ratio of 2.2 Revenues: $497 million, up 18% from third quarter of 2017 Operating Income: $29.4 million for an operating margin of 5.9% Diluted EPS: $0.55, up 41% from third quarter of 2017 Cash Flow …
Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMergeAbstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology Meeting (ASH) in DecemberConference call scheduled for 4:30 p.m. …
SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results for the quarter …
Southfield, Michigan, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been recognized by Great Place to Work® and FORTUNE as one of the 100 Best …
05 days 00:59:45
